The verdict was eagerly awaited. This Tuesday, April 20, the European Medicines Agency, the EMA, issued its opinion on the Janssen vaccine, pharmaceutical division of Johnson & Johnson. Indeed, its deployment is postponed in Europe and suspended in the United States.
Are blood clots a side effect of the Johnson & Johnson vaccine?
It was during a virtual press conference that the various experts gave their opinion on the Johnson & Johnson vaccine. The EMA has decided. She believes that blood clots should be added to the list of rare side effects of the Johnson & Johnson vaccine, like the Vaxzevria vaccine (AstraZeneca). The benefits outweigh the risks and therefore the balance remains “positive”. Many countries were waiting for the Agency’s recommendations, because the Johnson & Johnson vaccine should help speed up the vaccination campaign. The United States and India, from the first husband, want to extend it to all adults. As for France, it has already received doses of the vaccine, stored and ready to be delivered to doctors and pharmacists. Vaccinations with Johnson & Johnson could start in the week of April 26.
Why is the Johnson & Johnson vaccine suspended?
The US health authorities asked, the week of April 12, a “pause”In the use of this single dose serum. Indeed, the EMA was to investigate and analyze serious cases of blood clots, which occurred in a few people in the United States, after the injection. A few hours later, the Johnson & Johnson laboratory announced that during the investigation, the deployment of their vaccine will be postponed in Europe.
